These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 35526750

  • 1. Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration.
    Wang P, Xing H, Zhang F, Liu S, Lu Y, Zhang X, Yang J, Sun T.
    Int J Antimicrob Agents; 2022 Jul; 60(1):106599. PubMed ID: 35526750
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of polymyxin B and dosage strategy in critically ill patients with/without continuous renal replacement therapy.
    Luo X, Zhang Y, Liang P, Zhu H, Li M, Ding X, Zhang J.
    Eur J Pharm Sci; 2022 Aug 01; 175():106214. PubMed ID: 35609779
    [Abstract] [Full Text] [Related]

  • 3. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N, Mbatchi LC, Maseda E, Luque S, Grau S, Wallis SC, Muller L, Lipman J, Roberts JA, Lefrant JY, Roger C.
    Ther Drug Monit; 2021 Dec 01; 43(6):747-755. PubMed ID: 33560097
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW.
    Pharmacotherapy; 2019 Nov 01; 39(11):1066-1076. PubMed ID: 31549737
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of polymyxin B and proposed dosing regimens in elderly patients with multi-drug-resistant Gram-negative bacterial infections.
    Wang P, Liu D, Sun T, Zhang X, Yang J.
    Int J Antimicrob Agents; 2022 Nov 01; 60(5-6):106693. PubMed ID: 36375775
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Lefrant JY, Roberts JA.
    Antimicrob Agents Chemother; 2016 Aug 01; 60(8):4901-9. PubMed ID: 27270279
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA, Roberts DM, Udy AA, Mat-Nor MB, Mohamad-Nor FS, Wallis SC, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2015 Jul 01; 46(1):39-44. PubMed ID: 25881872
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
    Sin JH, Newman K, Elshaboury RH, Yeh DD, de Moya MA, Lin H.
    J Antimicrob Chemother; 2018 Jan 01; 73(1):199-203. PubMed ID: 29040561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
    Gao C, Tong J, Yu K, Sun Z, An R, Du Z.
    Eur J Clin Pharmacol; 2016 Jul 01; 72(7):823-30. PubMed ID: 27023465
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.
    Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, Behle TF, Bordinhão RC, Wang J, Forrest A, Nation RL, Li J, Zavascki AP.
    Clin Infect Dis; 2013 Aug 01; 57(4):524-31. PubMed ID: 23697744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.